Literature DB >> 12010742

Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression.

Martin C Kammerl1, Wolfgang Richthammer, Armin Kurtz, Bernhard K Krämer.   

Abstract

Salt restriction leads to parallel increases of renin, cyclooxygenase-2 (COX-2), and neuronal nitric oxide synthase (nNOS) gene expression in the juxtaglomerular apparatus of rat kidneys. Because the upregulation of these genes is strongly enhanced if salt restriction is combined with inhibition of the renin-angiotensin-aldosterone system, our study aimed to find out whether the juxtaglomerular expressions of renin, COX-2, and nNOS are subject to a common direct negative feedback control by ANG II. For this purpose, male Sprague-Dawley rats were fed a low-salt diet (0.02% wt/wt) with or without additional treatment with the ANG I-converting enzyme (ACE) inhibitor ramipril (10 mg x kg body wt(-1) x day(-1)) for 1 wk, and renocortical renin, COX-2, and nNOS mRNAs were assayed. To narrow down possible indirect effects of the ACE inhibitor that may result from insufficient aldosterone production, the animals received mineralocorticoid substitution with fludrocortisone (6 mg. kg body wt(-1) x day(-1)). Thus mineralocorticoid substitution prevented the fall of systolic blood pressure and of glomerular filtration induced by ramipril in rats on low-salt diet. Although fludrocortisone had no effect on basal renin, COX-2, and nNOS mRNA, it clearly attenuated the threefold increases of both renin and COX-2 mRNA in response to low-salt diet. In rats on low-salt diet, ramipril further increased renin mRNA ninefold, COX-2 mRNA fourfold, and nNOS 2.5-fold in the absence of fludrocortisone. In the presence of fludrocortisone, ramipril increased renin mRNA 10-fold, COX-2 mRNA 2.5-fold, and nNOS mRNA 2.5-fold. These data indicate that mineralocorticoid substitution lowers the overall expression of juxtaglomerular renin and COX-2 during low-salt intake and attenuates a further rise of COX-2 expression by ACE inhibition, but it does not change the stimulatory effect of ACE inhibition on renin and nNOS expression. We conclude that the expression of renin, COX-2, and nNOS in the juxtaglomerular apparatus during low-salt diet is markedly limited by a direct feedback inhibition through ANG II.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010742     DOI: 10.1152/ajpregu.00464.2001

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney.

Authors:  Carlos P Vio; Mariana Quiroz-Munoz; Catherina A Cuevas; Carlos Cespedes; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

2.  Everolimus treatment downregulates renocortical cyclooxygenase-2 expression in the rat kidney.

Authors:  Klaus Höcherl; Corina Hensel; Bettina Ulbricht; Bernhard K Krämer
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume.

Authors:  Julian M Stewart; June L Glover; Marvin S Medow
Journal:  Clin Sci (Lond)       Date:  2006-02       Impact factor: 6.124

4.  Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.

Authors:  Magali Araujo; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 5.  Renin: origin, secretion and synthesis.

Authors:  Pontus B Persson
Journal:  J Physiol       Date:  2003-08-29       Impact factor: 5.182

6.  Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.

Authors:  Minolfa C Prieto-Carrasquero; Lisa M Harrison-Bernard; Hiroyuki Kobori; Yuri Ozawa; Kathleen S Hering-Smith; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2004-06-28       Impact factor: 10.190

7.  Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen.

Authors:  Estrellita Uijl; Dien Ye; Liwei Ren; Katrina M Mirabito Colafella; Richard van Veghel; Ingrid M Garrelds; Hong S Lu; Alan Daugherty; Ewout J Hoorn; Paul Nioi; Don Foster; A H Jan Danser
Journal:  J Am Heart Assoc       Date:  2022-07-25       Impact factor: 6.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.